🇺🇸 FDA
Pipeline program

ORX750

ORX750-0201

Phase 2 small_molecule active

Quick answer

ORX750 for Narcolepsy Type 1 is a Phase 2 program (small_molecule) at Centessa Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).

Program details

Company
Centessa Pharmaceuticals plc
Indication
Narcolepsy Type 1
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials